CM
CRBP icon

Caption Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Caption Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.8K Sell
6,470
-49,596
-88% -$418K ﹤0.01% 1419
2025
Q4 		$456K Buy
+56,066
New +$692K ﹤0.01% 1257
2021
Q3 		– Sell
-8,960
Closed -$492K – 1549
2021
Q2 		$492K Buy
+8,960
New +$497K 0.01% 1042

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Caption Management's CRBP Position: Q1 2026 in Review

Caption Management reduced its Corbus Pharmaceuticals (CRBP) stake by 88% in Q1 2026, selling an estimated $418K and leaving 6,470 shares worth $60.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1419.

Caption Management first reported a position in CRBP in Q2 2021 and has held it in 3 quarters since. The position peaked at $492K in Q2 2021. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Caption Management held 6,470 shares of Corbus Pharmaceuticals worth $60.8K as of Q1 2026.
  • Caption Management sold 49,596 Corbus Pharmaceuticals shares in Q1 2026, an estimated $418K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1419 holding.
  • Caption Management first reported a position in Corbus Pharmaceuticals in Q2 2021 and has held it in 3 quarters since.
  • Caption Management's Corbus Pharmaceuticals position peaked at $492K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.